SANBIO
SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, is currently in a Phase 2b clinical trial for treatment of chronic motor impairments resulting from stroke with its joint development partner, Sumitomo Dainippon Pharma Co., Ltd., in the United States and Canada. SanBio is also implementing a global Phase 2 clinical trial in the United States and Japan using SB623 for treatment of motor impairment resulting from traumatic brain injury.
SANBIO
Social Links:
Industry:
Agriculture Biopharma Biotechnology Pharmaceutical
Founded:
2013-02-27
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.sanbio.com
Total Employee:
11+
Status:
Active
Contact:
+81362643481
Email Addresses:
[email protected]
Total Funding:
48.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Microsoft Exchange Online
Similar Organizations
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Nissay Capital
Nissay Capital investment in Post-IPO Equity - SanBio
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking investment in Post-IPO Equity - SanBio
Mizuho Bank
Mizuho Bank investment in Post-IPO Equity - SanBio
California Institute of Regenerative Medicine (CIRM)
California Institute of Regenerative Medicine (CIRM) investment in Grant - SanBio
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking investment in Post-IPO Equity - SanBio
SMBC Venture Capital
SMBC Venture Capital investment in Seed Round - SanBio
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Seed Round - SanBio
Official Site Inspections
http://www.sanbio.com Semrush global rank: 1.22 M Semrush visits lastest month: 25.09 K
- Host name: a7c5b2a362d47a4bb.awsglobalaccelerator.com
- IP address: 15.197.194.155
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SanBio"
Company Profile | SanBio - Official Site - ใตใณใใคใช
SanBio, Inc. Founded February 2001 SanBio, Ltd. Established February 2013 Representative Directors Keita Mori, President Toru Kawanishi, Executive Chairman Founding Scientist Dr. โฆSee details»
SanBio - Crunchbase Company Profile & Funding
SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, is currently in a Phase 2b clinical trial for treatment of chronic โฆSee details»
About Us | SanBio - Official Site
SanBio is focused on regenerative cell medicines for neurological disorders such as stroke, traumatic brain injury, diseases of the eye, and Parkinson's disease. SB643 is in Clinical Trials โฆSee details»
Sanbio - Crunchbase Company Profile & Funding
Organization. Sanbio . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Sanbio is located in Uden, Noord-Brabant, The Netherlands. Who are โฆSee details»
SanBio, Inc. - LinkedIn
SanBio, Inc. | 2,148 followers on LinkedIn. Founded in February 2001 SanBio's scope of business is development, production and sales of regenerative cell medicines. Our mission is to develop ...See details»
SanBio - Funding, Financials, Valuation & Investors - Crunchbase
SanBio is a regenerative medicine company that provides research, development, production, and sales of regenerative cell medicines. Search Crunchbase. ... How much funding has this โฆSee details»
SanBio Company Profile - Office Locations, Competitors, Revenue โฆ
Jul 3, 2024 SanBio (ใตใณใใคใชๆ ชๅผไผ็คพ) is a biotech company engaged in the development of regenerative medicine. It offers SB623, a cell-based investigational product made from โฆSee details»
Corporate Governance | SanBio - Regenerative Cell โฆ
SanBio Company, Ltd. recognizes that improvement of corporate governance is an important management issue. For this purpose, the company continuously endeavors to upgrade internal business monitoring and implement information โฆSee details»
SanBio Co Ltd, 4592:TYO profile - FT.com - Financial Times
Nov 22, 2024 SanBio Co Ltd is engaged in the regenerative cell business using allogeneic stem cells. The Company has the research and development base in the United States and โฆSee details»
Sanbio Company Profile - Office Locations, Competitors, Revenue โฆ
Sanbio is a distributor and manufacturer of life science products and services for research and diagnostics. Its research area includes cell biology, environmental, genomics, immunology, โฆSee details»
SanBio Obtains Marketing Approval for "AKUUGO® Suspension โฆ
TOKYO, July 31, 2024--SanBio Co., Ltd. (TOKYO:4592) (head office: Tokyo, representative director & CEO: Keita Mori) hereby announces that today on July 31 2024, it obtained โฆSee details»
SanBio Joins the Newly Formed National TBI Registry ... - Business โฆ
Dec 15, 2021 Sanbio announced it is one of the founding member organizations of the National TBI Registry Coalition (NTRC) in the United States. ... (NTRC) as a Founding Member โฆSee details»
SanBio - Contacts, Employees, Board Members, Advisors & Alumni โฆ
SanBio is a regenerative medicine company that provides research, development, production, and sales of regenerative cell medicines.See details»
Leadership | SanBio - Official Site
SanBio Co., Ltd. Executive Chairman. Toru Kawanishi. Mr. Kawanishi served as SanBio's Chairman of the Board from 2001 to 2005 and has been Co-Chief Executive Officer and a โฆSee details»
News | SanBio - Official Site
Nov 29, 2022 SanBioโs Strengths. R&D. SB623 Pipeline Technology. Delivering medical care to a large number of patients Large-scale Production Technology World-Leading Development โฆSee details»
SanBio Announces Publication Comparing Outcome Measures for โฆ
Nov 1, 2021 The Company is headquartered in Tokyo, Japan, Mountain View, California, US, and SanBio Asia Pte. Ltd. of Singapore), and additional information about SanBio Group is โฆSee details»
Mission&Vision | SanBio - Official Site - ใตใณใใคใช
SanBio is focused on regenerative cell medicines for neurological disorders such as stroke, traumatic brain injury, diseases of the eye, and Parkinson's disease. SB643 is in Clinical Trials โฆSee details»
CEO Message | SanBio - Official Site - ใตใณใใคใช
Apr 25, 2024 SanBio is focused on regenerative cell medicines for neurological disorders such as stroke, traumatic brain injury, diseases of the eye, and Parkinson's disease. SB643 is in โฆSee details»
Only Sanbio - Crunchbase Company Profile & Funding
Organization. Only Sanbio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. Only Sanbio is a synthetic biotechnology company integrating R&D, โฆSee details»